1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cancer of Nasopharynx in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiou, SH; Chow, KC; Tsai, MH | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cancer of Nasopharynx
Article | Year |
---|---|
Effect of platelet activating factor and butyrate on the expression of interleukin-2 receptor alpha in nasopharyngeal carcinoma cells.
Topics: Adult; Animals; Blotting, Western; Butyrates; Cells, Cultured; Chloramphenicol O-Acetyltransferase; DNA Primers; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Immunoenzyme Techniques; In Situ Hybridization; Male; Mice; Mice, SCID; Middle Aged; Nasopharyngeal Neoplasms; Platelet Activating Factor; Prognosis; Receptors, Interleukin-2; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Tumor Cells, Cultured | 2001 |